IFRS 2: Measuring Share Awards Without an Exercise Price

Share-based payment arrangements are a cornerstone of modern employee compensation, aligning employee interests with shareholder value. Under IFRS 2 Share-Based Payment, accounting for these awards requires careful measurement. While many might be familiar with valuing share options, which typically come with an exercise price, a different approach applies to awards like Restricted Stock Units (RSUs) or similar arrangements that lack this feature.

This post zeroes in on how to measure the fair value of such 'no exercise price' share awards. Unlike traditional options, where employees pay a set amount to acquire shares, RSUs typically grant shares for free once specific vesting conditions are met. This fundamental difference drives their valuation methodology.

The Core Principle: Fair Value of the Equity Instrument Itself

For share awards without an exercise price, IFRS 2 generally dictates that their fair value is based on the fair value of the underlying equity instrument – that is, the company's shares – on the grant date. Simply put, if your company's shares are trading at $50 on the grant date, and an RSU entitles an employee to one share, the fair value of that RSU is initially considered to be $50, before considering any other factors.

This direct approach contrasts sharply with share options that have an exercise price. Options derive their value from the potential future appreciation of the share price above the exercise price, along with other factors like time to maturity and volatility. Therefore, options require complex option pricing models (e.g., Black-Scholes or binomial models) for their valuation. For awards like RSUs, such models are not appropriate because there is no 'exercise price' hurdle to overcome.

Key Measurement Considerations

Starting Point: The Share Price

The most straightforward input is the market price of the company's shares at the grant date. This observable market price is the foundation for determining the RSU's fair value. If the shares are publicly traded, this is usually the closing price on that day.

Impact of Vesting Conditions

Vesting conditions are critical. IFRS 2 distinguishes between two types:

#### Non-Market Vesting Conditions

These are conditions related to an employee's service (e.g., remaining with the company for three years) or performance (e.g., achieving specific sales targets). Non-market vesting conditions do not affect the fair value *per share* of the RSU at the grant date. Instead, they impact the *number of awards* expected to vest. The cumulative expense recognised over the vesting period is adjusted to reflect the actual number of awards that ultimately vest.

#### Market Vesting Conditions

These conditions are linked to the entity's share price or the share price of another entity in the group (e.g., the share price reaching a certain level, or total shareholder return targets). Unlike non-market conditions, market vesting conditions *are* factored into the grant-date fair value measurement. This typically involves using a valuation technique that incorporates the probability of meeting these market conditions into the share's fair value.

Restrictions on Transferability

If the shares granted have restrictions on their transferability after vesting – for example, a lock-up period – this might lead to a reduction in their fair value. Such restrictions reduce the liquidity of the shares, and a discount may be applied to reflect this lack of marketability.

Accounting Treatment

Once the grant-date fair value per award is determined, the total fair value of the awards expected to vest is recognised as an expense over the vesting period, with a corresponding increase in equity. As mentioned, for non-market vesting conditions, this expense is adjusted over time to reflect the actual number of awards expected to vest.

Conclusion

Measuring share awards without an exercise price under IFRS 2, such as RSUs, is generally more direct than valuing traditional share options. The process begins with the fair value of the underlying equity instrument at the grant date, adjusted for any market vesting conditions and transfer restrictions. Understanding these principles ensures accurate financial reporting and transparency in employee compensation accounting.